Loading...

Michael Kelner

Title(s)Professor, Pathology
SchoolHealth Sciences
Phone858-657-5731
Emailmkelner@ucsd.edu
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Halogenated Alkenes and Microsomal GSH-transferases
    NIH/NIEHS R01ES013687Aug 8, 2006 - Apr 30, 2012
    Role: Principal Investigator
    ALTERATION OF ERCC GENE EXPRESSION IN VITRO AND IN VIVO
    NIH/NIA R01AG013153Aug 1, 1996 - Jul 31, 2000
    Role: Principal Investigator
    Coordinated Regulation of Antioxidant Enzymes
    NIH/NCI R01CA052310Apr 1, 1992 - Jun 30, 2006
    Role: Principal Investigator
    GENETIC INSIGHT INTO OXIDATIVE DAMAGE
    NIH/NIA R01AG010746Jan 15, 1992 - Dec 31, 1995
    Role: Principal Investigator
    GPX1 ENZYME REGULATION BY OXIDATIVE XENOBIOTICS
    NIH/NIEHS R01ES004989Jul 1, 1990 - Nov 30, 2004
    Role: Principal Investigator
    INHIBITION OF PARAQUAT OXYGEN-MEDIATED TOXICITY
    NIH/NIEHS K08ES000142Jul 1, 1985 - Jan 31, 1989
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bevins NJ, Hubbard JA, Fitzgerald RL, Kelner MJ. A Dilution Method to Mitigate Biotin Interference in Cardiac Troponin T Testing. J Appl Lab Med. 2019 11; 4(3):415-421. PMID: 31659079.
      View in: PubMed
    2. Bräutigam L, Zhang J, Dreij K, Spahiu L, Holmgren A, Abe H, Tew KD, Townsend DM, Kelner MJ, Morgenstern R, Johansson K. MGST1, a GSH transferase/peroxidase essential for development and hematopoietic stem cell differentiation. Redox Biol. 2018 07; 17:171-179. PMID: 29702404.
      View in: PubMed
    3. Staake MD, Kashinatham A, McMorris TC, Estes LA, Kelner MJ. Hydroxyurea derivatives of irofulven with improved antitumor efficacy. Bioorg Med Chem Lett. 2016 Apr 01; 26(7):1836-8. PMID: 26922141.
      View in: PubMed
    4. Kelner MJ, Diccianni MB, Yu AL, Rutherford MR, Estes LA, Morgenstern R. Absence of MGST1 mRNA and protein expression in human neuroblastoma cell lines and primary tissue. Free Radic Biol Med. 2014 Apr; 69:167-71. PMID: 24486338.
      View in: PubMed
    5. Li K, Ku G, Yan M, Broome HE, Kelner M, Wang HY. A rare and unique case of aggressive IgE-? plasma cell myeloma in a 28-year-old woman presented initially as an orbital mass. Hum Pathol. 2012 Dec; 43(12):2376-84. PMID: 23084304.
      View in: PubMed
    6. McMorris TC, Chimmani R, Alisala K, Staake MD, Banda G, Kelner MJ. Structure-activity studies of urea, carbamate, and sulfonamide derivatives of acylfulvene. J Med Chem. 2010 Feb 11; 53(3):1109-16. PMID: 20067264.
      View in: PubMed
    7. Stadalman KA, Kelner MJ, Box K, Dominguez A, Rigby JF. Stability of levothyroxine sodium 0.4 microg/mL in 0.9% sodium chloride injection. Prog Transplant. 2009 Dec; 19(4):354-6; quiz 357. PMID: 20050459.
      View in: PubMed
    8. Vohra R, Kelner M, Clark RF. Preparation of crotaline F-ab antivenom (CroFab) with automated mixing methods: in vitro observations. Clin Toxicol (Phila). 2009 Jan; 47(1):69-71. PMID: 19153853.
      View in: PubMed
    9. Vohra R, Clark R, Kelner M. CroFab reconstitution in various media: an in vitro solubility study. Clin Toxicol (Phila). 2008 Nov; 46(9):808-10. PMID: 18821147.
      View in: PubMed
    10. Kelner MJ, McMorris TC, Rojas RJ, Estes LA, Suthipinijtham P. Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model. Cancer Chemother Pharmacol. 2008 Dec; 63(1):19-26. PMID: 18305940.
      View in: PubMed
    11. Kelner MJ, McMorris TC, Rojas RJ, Estes LA, Suthipinijtham P. Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil. Invest New Drugs. 2008 Oct; 26(5):407-15. PMID: 18227973.
      View in: PubMed
    12. Nguyen N, Bonzo JA, Chen S, Chouinard S, Kelner MJ, Hardiman G, Bélanger A, Tukey RH. Disruption of the ugt1 locus in mice resembles human Crigler-Najjar type I disease. J Biol Chem. 2008 Mar 21; 283(12):7901-11. PMID: 18180294.
      View in: PubMed
    13. McMorris TC, Chimmani R, Gurram M, Staake MD, Kelner MJ. Synthesis and antitumor activity of amine analogs of irofulven. Bioorg Med Chem Lett. 2007 Dec 15; 17(24):6770-2. PMID: 17977722.
      View in: PubMed
    14. Roboz GJ, Giles FJ, Ritchie EK, Allen-Bard S, Curcio TJ, Wilkes MA, Park SL, Kantarjian HM, Faderl S, Ravandi F, Kelner MJ, Feldman EJ. Phase I/II study of continuous-infusion troxacitabine in refractory acute myeloid leukemia. J Clin Oncol. 2007 Jan 01; 25(1):10-5. PMID: 17146106.
      View in: PubMed
    15. Kelner MJ, Bagnell RD, Morgenstern R. Structural organization of the murine microsomal glutathione S-transferase gene (MGST1) from the 129/SvJ strain: identification of the promoter region and a comprehensive examination of tissue expression. Biochim Biophys Acta. 2004 May 25; 1678(2-3):163-9. PMID: 15157743.
      View in: PubMed
    16. McMorris TC, Staake MD, Kelner MJ. Synthesis and biological activity of enantiomers of antitumor irofulven. J Org Chem. 2004 Feb 06; 69(3):619-23. PMID: 14750783.
      View in: PubMed
    17. McMorris TC, Cong Q, Kelner MJ. Structure-activity relationship studies of illudins: analogues possessing a spiro-cyclobutane ring. J Org Chem. 2003 Dec 12; 68(25):9648-53. PMID: 14656090.
      View in: PubMed
    18. Ekström L, Lyrenäs L, Jakobsson PJ, Morgenstern R, Kelner MJ. Basal expression of the human MAPEG members microsomal glutathione transferase 1 and prostaglandin E synthase genes is mediated by Sp1 and Sp3. Biochim Biophys Acta. 2003 Jun 19; 1627(2-3):79-84. PMID: 12818425.
      View in: PubMed
    19. McMorris TC, Moon SS, Kelner MJ. Reaction of irofulven with zinc and acid. J Nat Prod. 2003 Feb; 66(2):310-2. PMID: 12608875.
      View in: PubMed
    20. Jaspers NG, Raams A, Kelner MJ, Ng JM, Yamashita YM, Takeda S, McMorris TC, Hoeijmakers JH. Anti-tumour compounds illudin S and Irofulven induce DNA lesions ignored by global repair and exclusively processed by transcription- and replication-coupled repair pathways. DNA Repair (Amst). 2002 Dec 05; 1(12):1027-38. PMID: 12531012.
      View in: PubMed
    21. McMorris TC, Kashinatham A, Lira R, Rundgren H, Gantzel PK, Kelner MJ, Dawe R. Sesquiterpenes from Omphalotus illudens. Phytochemistry. 2002 Oct; 61(4):395-8. PMID: 12377232.
      View in: PubMed
    22. Kelner MJ, McMorris TC, Rojas RJ, Trani NA, Velasco TR, Estes LA, Suthipinijtham P. Enhanced antitumor activity of irofulven in combination with antimitotic agents. Invest New Drugs. 2002 Aug; 20(3):271-9. PMID: 12201490.
      View in: PubMed
    23. Kelner MJ, McMorris TC, Rojas RJ, Trani NA, Estes L. Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C. Cancer Chemother Pharmacol. 2002 May; 49(5):412-8. PMID: 11976836.
      View in: PubMed
    24. McMorris TC, Yu J, Lira R, Dawe R, MacDonald JR, Waters SJ, Estes LA, Kelner MJ. Structure-activity studies of antitumor agent irofulven (hydroxymethylacylfulvene) and analogues. J Org Chem. 2001 Sep 07; 66(18):6158-63. PMID: 11529745.
      View in: PubMed
    25. Ingels M, Kelner MJ, Clark RF. The effect of gamma hydroxybutyrate on serum osmolality. J Toxicol Clin Toxicol. 2001; 39(4):417-8. PMID: 11527239.
      View in: PubMed
    26. McMorris TC, Lira R, Gantzel PK, Kelner MJ, Dawe R. Sesquiterpenes from the basidiomycete Omphalotus illudens. J Nat Prod. 2000 Nov; 63(11):1557-9. PMID: 11087609.
      View in: PubMed
    27. McMorris TC, Yu J, Ngo HT, Wang H, Kelner MJ. Preparation and biological activity of amino acid and peptide conjugates of antitumor hydroxymethylacylfulvene. J Med Chem. 2000 Sep 21; 43(19):3577-80. PMID: 11000013.
      View in: PubMed
    28. Kelner MJ, Bagnell RD, Montoya MA, Lanham KA. Structural organization of the human gastrointestinal glutathione peroxidase (GPX2) promoter and 3'-nontranscribed region: transcriptional response to exogenous redox agents. Gene. 2000 May 02; 248(1-2):109-16. PMID: 10806356.
      View in: PubMed
    29. Kelner MJ, Bagnell RD, Montoya MA, Estes LA, Forsberg L, Morgenstern R. Structural organization of the microsomal glutathione S-transferase gene (MGST1) on chromosome 12p13.1-13.2. Identification of the correct promoter region and demonstration of transcriptional regulation in response to oxidative stress. J Biol Chem. 2000 Apr 28; 275(17):13000-6. PMID: 10777602.
      View in: PubMed
    30. Kelner MJ, Montoya MA. Structural organization of the human glutathione reductase gene: determination of correct cDNA sequence and identification of a mitochondrial leader sequence. Biochem Biophys Res Commun. 2000 Mar 16; 269(2):366-8. PMID: 10708558.
      View in: PubMed
    31. Kelner MJ, McMorris TC, Estes LA, Oval MY, Rojas RJ, Lynn JR, Lanham KA, Samson KM. Efficacy of MGI 114 (HMAF) against the MRP+ metastatic MV522 lung carcinoma xenograft. Anticancer Drugs. 2000 Mar; 11(3):217-24. PMID: 10831281.
      View in: PubMed
    32. Kelner MJ, McMorris TC, Estes L, Samson KM, Trani NA, MacDonald JR. Anti-leukemic action of the novel agent MGI 114 (HMAF) and synergistic action with topotecan. Leukemia. 2000 Jan; 14(1):136-41. PMID: 10637489.
      View in: PubMed
    33. McMorris TC, Elayadi AN, Yu J, Hu Y, Kelner MJ. Metabolism of antitumor hydroxymethylacylfulvene by rat liver cytosol. Drug Metab Dispos. 1999 Sep; 27(9):983-5. PMID: 10460795.
      View in: PubMed
    34. Estonius M, Forsberg L, Danielsson O, Weinander R, Kelner MJ, Morgenstern R. Distribution of microsomal glutathione transferase 1 in mammalian tissues. A predominant alternate first exon in human tissues. Eur J Biochem. 1999 Mar; 260(2):409-13. PMID: 10095775.
      View in: PubMed
    35. Kelner MJ, McMorris TC, Montoya MA, Estes L, Uglik SF, Rutherford M, Samson KM, Bagnell RD, Taetle R. Characterization of MGI 114 (HMAF) histiospecific toxicity in human tumor cell lines. Cancer Chemother Pharmacol. 1999; 44(3):235-40. PMID: 10453725.
      View in: PubMed
    36. McMorris TC, Elayadi AN, Yu J, Kelner MJ. Metabolism of antitumor acylfulvene by rat liver cytosol. Biochem Pharmacol. 1999 Jan 01; 57(1):83-8. PMID: 9920288.
      View in: PubMed
    37. de Haan JB, Bladier C, Griffiths P, Kelner M, O'Shea RD, Cheung NS, Bronson RT, Silvestro MJ, Wild S, Zheng SS, Beart PM, Hertzog PJ, Kola I. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J Biol Chem. 1998 Aug 28; 273(35):22528-36. PMID: 9712879.
      View in: PubMed
    38. Kelner MJ, Montoya MA. Structural organization of the human selenium-dependent phospholipid hydroperoxide glutathione peroxidase gene (GPX4): chromosomal localization to 19p13.3. Biochem Biophys Res Commun. 1998 Aug 10; 249(1):53-5. PMID: 9705830.
      View in: PubMed
    39. Kelner MJ, McMorris TC, Estes L, Samson KM, Bagnell RD, Taetle R. Efficacy of MGI 114 (6-hydroxymethylacylfulvene, HMAF) against the mdr1/gp170 metastatic MV522 lung carcinoma xenograft. Eur J Cancer. 1998 May; 34(6):908-13. PMID: 9797706.
      View in: PubMed
    40. Kelner MJ, McMorris TC, Montoya MA, Estes L, Uglik SF, Rutherford M, Samson KM, Bagnell RD, Taetle R. Characterization of acylfulvene histiospecific toxicity in human tumor cell lines. Cancer Chemother Pharmacol. 1998; 41(3):237-42. PMID: 9443641.
      View in: PubMed
    41. McMorris TC, Yu J, Hu Y, Estes LA, Kelner MJ. Design and Synthesis of Antitumor Acylfulvenes. J Org Chem. 1997 May 02; 62(9):3015-3018. PMID: 11671671.
      View in: PubMed
    42. MacDonald JR, Muscoplat CC, Dexter DL, Mangold GL, Chen SF, Kelner MJ, McMorris TC, Von Hoff DD. Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S. Cancer Res. 1997 Jan 15; 57(2):279-83. PMID: 9000568.
      View in: PubMed
    43. Kelner MJ, Estes L, Rutherford M, Uglik SF, Peitzke JA. Heterologous expression of carbonyl reductase: demonstration of prostaglandin 9-ketoreductase activity and paraquat resistance. Life Sci. 1997; 61(23):2317-22. PMID: 9408054.
      View in: PubMed
    44. de Haan JB, Wolvetang EJ, Cristiano F, Iannello R, Bladier C, Kelner MJ, Kola I. Reactive oxygen species and their contribution to pathology in Down syndrome. Adv Pharmacol. 1997; 38:379-402. PMID: 8895817.
      View in: PubMed
    45. Kelner MJ, McMorris TC, Montoya MA, Estes L, Rutherford M, Samson KM, Taetle R. Characterization of cellular accumulation and toxicity of illudin S in sensitive and nonsensitive tumor cells. Cancer Chemother Pharmacol. 1997; 40(1):65-71. PMID: 9137532.
      View in: PubMed
    46. McMorris TC, Kelner MJ, Wang W, Yu J, Estes LA, Taetle R. (Hydroxymethyl)acylfulvene: an illudin derivative with superior antitumor properties. J Nat Prod. 1996 Sep; 59(9):896-9. PMID: 8864242.
      View in: PubMed
    47. Kelner MJ, Stokely MN, Stovall NE, Montoya MA. Structural organization of the human microsomal glutathione S-transferase gene (GST12). Genomics. 1996 Aug 15; 36(1):100-3. PMID: 8812420.
      View in: PubMed
    48. de Haan JB, Cristiano F, Iannello R, Bladier C, Kelner MJ, Kola I. Elevation in the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide. Hum Mol Genet. 1996 Feb; 5(2):283-92. PMID: 8824885.
      View in: PubMed
    49. McMorris TC, Kelner MJ, Wang W, Diaz MA, Estes LA, Taetle R. Acylfulvenes, a new class of potent antitumor agents. Experientia. 1996 Jan 16; 52(1):75-80. PMID: 8575564.
      View in: PubMed
    50. Kelner MJ, McMorris TC, Estes L, Wang W, Samson KM, Taetle R. Efficacy of HMAF (MGI-114) in the MV522 metastatic lung carcinoma xenograft model nonresponsive to traditional anticancer agents. Invest New Drugs. 1996; 14(2):161-7. PMID: 8913837.
      View in: PubMed
    51. Kelner MJ, McMorris TC, Estes L, Starr RJ, Rutherford M, Montoya M, Samson KM, Taetle R. Efficacy of Acylfulvene Illudin analogues against a metastatic lung carcinoma MV522 xenograft nonresponsive to traditional anticancer agents: retention of activity against various mdr phenotypes and unusual cytotoxicity against ERCC2 and ERCC3 DNA helicase-deficient cells. Cancer Res. 1995 Nov 01; 55(21):4936-40. PMID: 7585533.
      View in: PubMed
    52. Kelner MJ, Bagnell RD, Uglik SF, Montoya MA, Mullenbach GT. Heterologous expression of selenium-dependent glutathione peroxidase affords cellular resistance to paraquat. Arch Biochem Biophys. 1995 Oct 20; 323(1):40-6. PMID: 7487071.
      View in: PubMed
    53. Kelner MJ, Uglik SF. Superoxide dismutase abolishes the platelet-derived growth factor-induced release of prostaglandin E2 by blocking induction of nitric oxide synthase: role of superoxide. Arch Biochem Biophys. 1995 Sep 10; 322(1):31-8. PMID: 7574691.
      View in: PubMed
    54. Kelner MJ, McMorris TC, Estes L, Starr R, Samson K, Varki N, Taetle R. Nonresponsiveness of the metastatic human lung carcinoma MV522 xenograft to conventional anticancer agents. Anticancer Res. 1995 May-Jun; 15(3):867-71. PMID: 7645973.
      View in: PubMed
    55. Kelner MJ, McMorris TC, Taetle R. In vitro and in vivo studies on the anticancer activity of dehydroilludin M. Anticancer Res. 1995 May-Jun; 15(3):873-8. PMID: 7645974.
      View in: PubMed
    56. Kelner MJ, Bagnell R, Montoya M, Estes L, Uglik SF, Cerutti P. Transfection with human copper-zinc superoxide dismutase induces bidirectional alterations in other antioxidant enzymes, proteins, growth factor response, and paraquat resistance. Free Radic Biol Med. 1995 Mar; 18(3):497-506. PMID: 9101240.
      View in: PubMed
    57. Kelner MJ, McMorris TC, Estes L, Rutherford M, Montoya M, Goldstein J, Samson K, Starr R, Taetle R. Characterization of illudin S sensitivity in DNA repair-deficient Chinese hamster cells. Unusually high sensitivity of ERCC2 and ERCC3 DNA helicase-deficient mutants in comparison to other chemotherapeutic agents. Biochem Pharmacol. 1994 Jul 19; 48(2):403-9. PMID: 8053936.
      View in: PubMed
    58. Kelner MJ, Uglik SF. Mechanism of prostaglandin E2 release and increase in PGH2/PGE2 isomerase activity by PDGF: involvement of nitric oxide. Arch Biochem Biophys. 1994 Jul; 312(1):240-3. PMID: 7518221.
      View in: PubMed
    59. Kelner MJ, Uglik SF. PDGF-induces the glutathione-dependent enzyme PGH2/PGE2 isomerase in NIH3T3 and pEJ transformed fibroblasts. Biochem Biophys Res Commun. 1994 Jan 14; 198(1):298-303. PMID: 8292033.
      View in: PubMed
    60. Kelner MJ. Thioureas and thioamides react with superoxide to form a novel product. Free Radic Biol Med. 1993 Feb; 14(2):225-6. PMID: 8381108.
      View in: PubMed
    61. Brandsteterová E, Kelner MJ, McMorris TC, Estes L, Bagnell R, Montoya M. HPLC determination of a new anticancer agent (acylfulvene) in serum. Neoplasma. 1992; 39(6):369-73. PMID: 1491727.
      View in: PubMed
    62. Kelner MJ, Bagnell R. Alteration of growth rate and fibronectin by imbalances in superoxide dismutase and glutathione peroxidase activity. Adv Exp Med Biol. 1991; 283:305-9. PMID: 2069002.
      View in: PubMed
    63. McMorris TC, Kelner MJ, Wang W, Moon S, Taetle R. On the mechanism of toxicity of illudins: the role of glutathione. Chem Res Toxicol. 1990 Nov-Dec; 3(6):574-9. PMID: 2103329.
      View in: PubMed
    64. Kelner MJ, McMorris TC, Taetle R. Preclinical evaluation of illudins as anticancer agents: basis for selective cytotoxicity. J Natl Cancer Inst. 1990 Oct 03; 82(19):1562-5. PMID: 2402017.
      View in: PubMed
    65. Kelner MJ, Bagnell R. Alteration of endogenous glutathione peroxidase, manganese superoxide dismutase, and glutathione transferase activity in cells transfected with a copper-zinc superoxide dismutase expression vector. Explanation for variations in paraquat resistance. J Biol Chem. 1990 Jul 05; 265(19):10872-5. PMID: 2358446.
      View in: PubMed
    66. Kelner MJ, Bagnell R, Welch KJ. Thioureas react with superoxide radicals to yield a sulfhydryl compound. Explanation for protective effect against paraquat. J Biol Chem. 1990 Jan 25; 265(3):1306-11. PMID: 2153125.
      View in: PubMed
    67. Kelner MJ, Bagnell R. Glutathione-dependent enzymes alone can produce paraquat resistance. Free Radic Biol Med. 1990; 9(2):149-53. PMID: 2172100.
      View in: PubMed
    68. Kelner MJ, Bagnell R. Paraquat resistance associated with reduced NADPH reductase in an energy-dependent paraquat-accumulating cell line. Arch Biochem Biophys. 1989 Nov 01; 274(2):366-74. PMID: 2802616.
      View in: PubMed
    69. Kelner MJ, Bagnell R, Hale B, Alexander NM. Inactivation of intracellular copper-zinc superoxide dismutase by copper chelating agents without glutathione depletion and methemoglobin formation. Free Radic Biol Med. 1989; 6(4):355-60. PMID: 2540068.
      View in: PubMed
    70. Roberts RT, Alexander NM, Kelner MJ. Definitive liquid-chromatographic demonstration that N-ethylglycine is the metabolite of lidocaine that interferes in the Kodak sarcosine oxidase-coupled method for creatinine. Clin Chem. 1988 Dec; 34(12):2569-72. PMID: 3197304.
      View in: PubMed
    71. Kelner MJ, Bagnell R, Hale B, Alexander NM. Methylene blue competes with paraquat for reduction by flavo-enzymes resulting in decreased superoxide production in the presence of heme proteins. Arch Biochem Biophys. 1988 May 01; 262(2):422-6. PMID: 2835006.
      View in: PubMed
    72. Kelner MJ, Bagnell R, Hale B, Alexander NM. Potential of methylene blue to block oxygen radical generation in reperfusion injury. Basic Life Sci. 1988; 49:895-8. PMID: 2855011.
      View in: PubMed
    73. Kelner MJ. Newer cardiac agents: antiarrhythmics and antianginal agents. Clin Lab Med. 1987 Sep; 7(3):567-85. PMID: 3308297.
      View in: PubMed
    74. Kelner MJ, McMorris TC, Beck WT, Zamora JM, Taetle R. Preclinical evaluation of illudins as anticancer agents. Cancer Res. 1987 Jun 15; 47(12):3186-9. PMID: 3472654.
      View in: PubMed
    75. Kelner MJ, Alexander NM. Endocrine hormone abnormalities in Amanita poisoning. J Toxicol Clin Toxicol. 1987; 25(1-2):21-37. PMID: 3586085.
      View in: PubMed
    76. Kelner MJ, McLenithan JC, Anders MW. Thiol stimulation of the cytochrome P-450-dependent reduction of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) to 1,1-dichloro-2,2-bis(p-chlorophenyl)ethane (DDD). Biochem Pharmacol. 1986 Jun 01; 35(11):1805-7. PMID: 3718529.
      View in: PubMed
    77. Kelner MJ, Alexander NM. Oxidation of glutathione by methylene blue is equivalent in G-6-PD deficient and normal erythrocytes. Res Commun Chem Pathol Pharmacol. 1986 May; 52(2):265-8. PMID: 3715203.
      View in: PubMed
    78. Kelner MJ, Alexander NM. Inhibition of erythrocyte superoxide dismutase by diethyldithiocarbamate also results in oxyhemoglobin-catalyzed glutathione depletion and methemoglobin production. J Biol Chem. 1986 Feb 05; 261(4):1636-41. PMID: 3003078.
      View in: PubMed
    79. Andranovich T, Kelner MJ. In vitro oxidation of uric acid in serum by methylene blue. Clin Chem. 1986 Jan; 32(1 Pt 1):177-9. PMID: 3940703.
      View in: PubMed
    80. Kelner MJ, Alexander NM. Methylene blue directly oxidizes glutathione without the intermediate formation of hydrogen peroxide. J Biol Chem. 1985 Dec 05; 260(28):15168-71. PMID: 4066667.
      View in: PubMed
    81. Kelner MJ, Alexander NM. Rapid separation and identification of myoglobin and hemoglobin in urine by centrifugation through a microconcentrator membrane. Clin Chem. 1985 Jan; 31(1):112-4. PMID: 3965185.
      View in: PubMed
    82. Kelner MJ, Bailey DN. Mismeasurement of methemoglobin ("methemoglobin revisited") Clin Chem. 1985 Jan; 31(1):168-9. PMID: 3965210.
      View in: PubMed
    83. Kelner MJ. Positive diphenhydramine interference in the EMIT-d.a.u. assay. Clin Chem. 1984 Aug; 30(8):1430. PMID: 6378429.
      View in: PubMed
    84. Kelner M, Bailey DN. Micro-analysis for quinidine in serum by thin-layer chromatography followed by fluorescence densitometry. Clin Chem. 1983 Dec; 29(12):2100-2. PMID: 6640909.
      View in: PubMed
    85. Kelner M, Bailey DN. Reversed-phase liquid-chromatographic simultaneous analysis for thiopental and pentobarbital in serum. Clin Chem. 1983 Jun; 29(6):1097-100. PMID: 6851102.
      View in: PubMed